Søgeresultater - John V. Heymach

Refine Results
  1. 1
    Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

    Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy af Ferdinandos Skoulidis, John V. Heymach

    Udgivet 2019
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  2. 2
    Two conserved domains in the NGF propeptide are necessary and sufficient for the biosynthesis of correctly processed and biologically active NGF.

    Two conserved domains in the NGF propeptide are necessary and sufficient for the biosynthesis of correctly processed and biologically active NGF. af Ueli Suter, John V. Heymach, E.M. Shooter

    Udgivet 1991
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Lung Cancer

    Lung Cancer af Roy S. Herbst, John V. Heymach, Scott M. Lippman

    Udgivet 2008
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  4. 4
    β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-Blockers

    β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-Blockers af Monique B. Nilsson, Xiuning Le, John V. Heymach

    Udgivet 2019
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  5. 5
    Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

    Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer af John V. Heymach, David H. Harpole, Martin Reck

    Udgivet 2024
    Få fuldtekst
    Carta
    Føj til favoritter
    Saved in:
  6. 6
    Current and future treatment options for <i>MET</i> exon 14 skipping alterations in non-small cell lung cancer

    Current and future treatment options for <i>MET</i> exon 14 skipping alterations in non-small cell lung cancer af Lingzhi Hong, Jianjun Zhang, John V. Heymach, Xiuning Le

    Udgivet 2021
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  7. 7
    The Regulated Secretion and Vectorial Targeting of Neurotrophins in Neuroendocrine and Epithelial Cells

    The Regulated Secretion and Vectorial Targeting of Neurotrophins in Neuroendocrine and Epithelial Cells af John V. Heymach, Alex Krüttgen, Ueli Suter, Eric M. Shooter

    Udgivet 1996
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  8. 8
    Neurotrophins induce release of neurotrophins by the regulated secretory pathway

    Neurotrophins induce release of neurotrophins by the regulated secretory pathway af Alex Krüttgen, Jens Carsten Möller, John V. Heymach, Eric M. Shooter

    Udgivet 1998
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    Predictive biomarkers in precision medicine and drug development against lung cancer

    Predictive biomarkers in precision medicine and drug development against lung cancer af Bingliang Fang, Reza J. Mehran, John V. Heymach, Stephen G. Swisher

    Udgivet 2015
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  10. 10
    Epidermal Growth Factor Receptor Inhibitors in Development for the Treatment of Non–Small Cell Lung Cancer

    Epidermal Growth Factor Receptor Inhibitors in Development for the Treatment of Non–Small Cell Lung Cancer af John V. Heymach, Monique B. Nilsson, George Blumenschein, Vassiliki A. Papadimitrakopoulou, Roy S. Herbst

    Udgivet 2006
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  11. 11
    Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis

    Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis af Christopher H. Lieu, John V. Heymach, Michael J. Overman, Hai T. Tran, Scott Kopetz

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  12. 12
    Beyond epidermal growth factor receptor: MET amplification as a general resistance driver to targeted therapy in oncogene-driven non-small-cell lung cancer

    Beyond epidermal growth factor receptor: MET amplification as a general resistance driver to targeted therapy in oncogene-driven non-small-cell lung cancer af Niamh Coleman, Lingzhi Hong, J. Zhang, John V. Heymach, David S. Hong, Xiuning Le

    Udgivet 2021
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  13. 13
    Antibody-drug conjugates in lung cancer: dawn of a new era?

    Antibody-drug conjugates in lung cancer: dawn of a new era? af Niamh Coleman, Timothy A. Yap, John V. Heymach, Funda Meric‐Bernstam, Xiuning Le

    Udgivet 2023
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  14. 14
    Positron Emission Tomography/Computed Tomography-Guided Intensity-Modulated Radiotherapy for Limited-Stage Small-Cell Lung Cancer

    Positron Emission Tomography/Computed Tomography-Guided Intensity-Modulated Radiotherapy for Limited-Stage Small-Cell Lung Cancer af Shervin M. Shirvani, Ritsuko Komaki, John V. Heymach, Frank V. Fossella, Joe Y. Chang

    Udgivet 2011
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  15. 15
    Targeted Therapies for Lung Cancer

    Targeted Therapies for Lung Cancer af Jill E. Larsen, Tina Cascone, David E. Gerber, John V. Heymach, John D. Minna

    Udgivet 2011
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  16. 16
    Axl Receptor Axis: A New Therapeutic Target in Lung Cancer

    Axl Receptor Axis: A New Therapeutic Target in Lung Cancer af Pavel A. Levin, Rolf A. Brekken, Lauren A. Byers, John V. Heymach, David E. Gerber

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  17. 17
    Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy

    Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy af Sonia Patel, Monique B. Nilsson, Xiuning Le, Tina Cascone, Rakesh K. Jain, John V. Heymach

    Udgivet 2022
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  18. 18
    Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype

    Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype af Y. Piao, Jingdan Liang, Lindsay Holmes, Amado J. Zurita, V. Henry, John V. Heymach, John de Groot

    Udgivet 2012
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  19. 19
    Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2

    Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2 af Xiao-Feng Le, Weiqun Mao, Chunhua Lu, Angela Thornton, John V. Heymach, Anil K. Sood, Robert C. Bast

    Udgivet 2008
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  20. 20
    miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer

    miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer af Dat T. Vo, Narasimha Kumar Karanam, Lianghao Ding, Debabrata Saha, John S. Yordy, Uma Giri, John V. Heymach, Michael D. Story

    Udgivet 2019
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: